Fiera Capital (Canada)
ARIA

Fiera Capital (Canada)’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Fiera Capital (Canada)’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,946
Closed -$149K – 819
2016
Q4 		$149K Sell
11,946
-4,202
-26% -$50.6K ﹤0.01% 741
2016
Q3 		$221K Buy
16,148
+143
+0.9% +$1.44K ﹤0.01% 683
2016
Q2 		$118K Buy
+16,005
New +$120K ﹤0.01% 737

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Fiera Capital (Canada)'s ARIA Position: Q1 2017 in Review

Fiera Capital (Canada) sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 11,946 shares — an estimated $149K sold.

Fiera Capital (Canada) first reported a position in ARIA in Q2 2016 and held it in 3 quarters. The position peaked at $221K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Fiera Capital (Canada) reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Fiera Capital (Canada) sold 11,946 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $149K.
  • Fiera Capital (Canada) first reported a position in Ariad Pharmaceuticals Inc in Q2 2016 and held it in 3 quarters.
  • Fiera Capital (Canada)'s Ariad Pharmaceuticals Inc position peaked at $221K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2017, filed 15 May 2017.